Clonidine Pill

DRUG5 trials

Sponsors

University of Iowa, Weill Medical College of Cornell University, Wake Forest University Health Sciences, University of Kansas Medical Center

Conditions

AnxietyBlood PressureCancerDiabetesDiuretics Drug ReactionsHealthy VolunteersHypertensionInsulin Resistance

Early Phase 1

Feasibility of Administering Clonidine as a Pharmacological Challenge in Imaging Studies

TerminatedNCT04030572

Weill Medical College of Cornell UniversityCancer, Neuro-Degenerative Disease

Start: 2019-12-10End: 2020-03-17Updated: 2021-06-24

PET Study of a2a Agonist Effects on the Ventricular CSF Clearance of [11C]Butanol

WithdrawnNCT04032691

Weill Medical College of Cornell UniversityHealthy Volunteers

Start: 2019-08-27End: 2021-05-24Updated: 2021-07-20

Phase 1

Mitigating the Pro-inflammatory Phenotype of Obesity

RecruitingNCT04934228

University of Kansas Medical CenterBlood Pressure, Diabetes, Diuretics Drug Reactions +3

Start: 2021-07-01End: 2027-08-01Target: 60Updated: 2025-06-05

Phase 3

Repurposing Low-Dose Clonidine for PTSD in Veterans

RecruitingNCT04877093

Wake Forest University Health SciencesPosttraumatic Stress Disorder, PTSD, Sleep

Start: 2023-06-01End: 2027-03-31Target: 32Updated: 2026-03-31

Phase 4

Anxiety-mediated Impairments in Large Elastic Artery Function and the Autonomic Nervous System

TerminatedNCT03109795

University of IowaAnxiety, Hypertension

Start: 2017-04-10End: 2023-06-30Updated: 2024-07-29